InvAscent
Finance
Flashback 2025: New PE record, large VC vehicles buoy fundraising momentum
India saw a homegrown private equity firm shattering fundraising records for the second year in a row in 2025 while ......
Healthcare
Can InvAscent, MO Alts beat the benchmark as portfolio firm readies for IPO?
Mid-market private equity firms InvAscent and Motilal Oswal Alternates (MO Alts) are planning to monetize their investments in a healthcare ......
Healthcare
Bottomline: PE-backed Sharp Sight polishes metrics ahead of potential merger, investor exit
Eye-care chain Sharp Sight Group of Eye Hospitals, which is in merger talks with ASG Eye Hospitals in a deal ......
Healthcare
InvAscent logs out of animal pharma company, sells stake to family office
Healthcare-focused private equity firm InvAscent has logged out of its nearly seven-year-old investment in an animal pharmaceuticals company through a ......
General
Deals Digest: PE/VC activity slows but M&A value jumps on a jumbo transaction
Private equity and venture capital investments fell during the five-day period ending Friday from the week before but the total ......
Healthcare
Large hospital majors eye stake in InvAscent portfolio company
A clutch of large hospital chains in the country are evaluating an investment in a maternity and paediatric-care services provider ......
Healthcare
ChrysCapital emerges frontrunner to buy into PE-backed CDMO firm
Homegrown private equity firm ChrysCapital has emerged as one of the frontrunners to invest in a local contract development and ......
Finance
InvAscent marks final close of fourth PE fund, falls shy of target
Healthcare-focused private equity firm InvAscent has marked the final close of its fourth fund that was floated in mid-2023 but ......
Healthcare
PE firm InvAscent backs multi-speciality hospital chain SRV Hospitals
Healthcare-focused private equity firm InvAscent, currently raising its fourth fund, has invested Rs 140 crore in SRV Hospitals, a Mumbai-based ......
Healthcare
InvAscent looks to log another exit from pharma portfolio
Healthcare-focused private equity firm InvAscent is looking to exit its more than six-year-old investment in an animal pharmaceuticals company, possibly ......





